regulatory guidance

Regulated life sciences moves fast, but regulations don’t bend for urgency. Regulatory strategy is how biotech, pharma, medical device, and laboratory teams turn scientific progress into compliant, market-ready execution without costly rework or surprises late in development. Done well, regulatory alignment accelerates timelines, improves confidence with partners, and reduces the risk of delays during reviews, audits, or scale-up.

Terraforme Biosciences provides practical regulatory guidance that connects requirements to real operations. We help teams interpret expectations, translate them into actionable quality and technical plans, and build the documentation and evidence regulators (and customers) look for. Our focus is clarity, defensibility, and momentum so you can make decisions with confidence.

Regulatory Guidance We Provide

Common support areas include regulatory strategy and readiness assessments, gap analyses against applicable frameworks, documentation planning, technical/quality narratives for partners and diligence, alignment of QMS/validation expectations to program stage, and audit/inspection support and response planning.

problems we solve

Navigating Complex Requirements Without Losing Speed

Many teams feel stuck between two risks: moving fast and missing key requirements, or over-building controls too early and slowing down innovation. Regulations and guidance documents can be dense, cross-referenced, and interpreted differently depending on product type, stage, and geography. Without a clear approach, teams make inconsistent decisions—then pay for it later through rework, delayed submissions, or unexpected findings.

We help you convert regulatory complexity into a practical roadmap. That means clarifying what applies (and what doesn’t), defining a right-sized compliance posture for your stage, and translating expectations into concrete deliverables: documentation plans, quality system components, validation scope, and evidence requirements. You get a clear “why,” a clear “what,” and a realistic “how.

Bridging R&D, Quality, and Operations

Regulatory risk often shows up at the interfaces: R&D hands off to Operations, Quality reviews a process that wasn’t designed for documentation, or scale-up introduces changes that aren’t properly justified. The science may be strong, but the traceability and control story is weak, especially around change management, comparability, method performance, and validation rationale.

We build alignment across functions so decisions are consistent and defensible. We support teams in defining requirements, documenting rationale, and creating traceability between development work and operational controls. The outcome is smoother tech transfer, fewer surprises during scale-up, and a clearer evidence trail that holds up in audits, partner reviews, and regulatory scrutiny

Inspection Readiness, Responses, and Commitments

Inspections and audits rarely fail on intent—they fail on clarity, evidence, and follow-through. Organizations can get caught off guard by how findings are framed, how quickly responses are required, and how difficult it is to propose corrective actions that are both effective and achievable. Poorly structured responses can create longer-term commitments that drain resources and disrupt operations.

We help you prepare proactively and respond effectively. That includes strengthening the underlying systems regulators assess, organizing evidence, coaching interview readiness, and developing response strategies that address root cause and prevent recurrence. When findings occur, we support clear, credible responses with practical CAPA plans built to be completed, verified, and sustained.